Summary
Lectins are naturally occurring, carbohydrate-binding molecules that can be isolated from diverse biological sources and used in the laboratory to investigate the presence of carbohydrate structures in or on cells, in much the same way as antibodies can be used to probe cells and tissues for the presence of specific antigens. As it is becoming increasingly apparent that subtle alterations in the glycosylation of cancer cells can profoundly influence their biological behavior (with consequent implications for patient outcome and prognosis), lectin histochemistry is a potentially useful modification of the more widely used technique of immunohistochemistry. This chapter provides an introductory background to lectins and their use in breast cancer research, and provides basic protocols for lectin histochemistry that highlight the important technical differences between this approach and immunohistochemistry. The methods given here are broadly applicable and can be modified to investigate virtually any glycosylation change of potential interest in breast cancer research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Brooks, S. A., Dwek, M. V., and Schumacher, U. (2002) Carbohydrate binding proteins (lectins) in Functional and Molecular Glycobiology. BIOS Scientific, Oxford, UK, pp. 227–247.
Brooks, S. A., Leathem, A. J. C., and Schumacher, U. (1997) An introduction to the field, in Lectin Histochemistry—A Concise Practical Handbook. BIOS Scientific, Oxford, UK, pp. 1–17.
Brooks, S. A. and Carter, T. M. (2001) N-acetylgalactosamine, N-acetylglucosmine and sialic acid expression by primary breast cancers. Histochem. J. 103, 37–51.
Brooks, S. A. (2000) The involvement of Helix pomatia lectin (HPA) binding N-acetylgalactosamine glycans in cancer progression. Histol. Histopathol. 15, 143–158.
Julien, S., Krzewinski-Recchi, M. A., Harduin-Lepers, A., et al. (2001) Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMPNeu5Ac: GalNAc α2,6-sialyltransferase (ST6GalNAc I) cDNA. Glycoconjugate J. 18, 883–893.
Burchell, J., Poulsom, R., Hanby, A., et al. (1999) An α2,3 sialyltransferase (ST3Gal I) is elevated in primary breast carcinomas. Glycobiology 9, 1307–1311.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc.
About this protocol
Cite this protocol
Carter, T.M., Brooks, S.A. (2006). Detection of Aberrant Glycosylation in Breast Cancer Using Lectin Histochemistry. In: Brooks, S.A., Harris, A. (eds) Breast Cancer Research Protocols. Methods in Molecular Medicine, vol 120. Humana Press, Totowa, NJ. https://doi.org/10.1385/1-59259-969-9:201
Download citation
DOI: https://doi.org/10.1385/1-59259-969-9:201
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-191-2
Online ISBN: 978-1-59259-969-1
eBook Packages: Springer Protocols